Recruitment

Recruitment Status
Unknown status

Inclusion Criterias

pathologic T3 tumours of esophagus or GEJ
pathologic T3 tumours of esophagus or GEJ

Exclusion Criterias

R2 resections
pT other than pT3
R2 resections
pT other than pT3

Summary

Conditions
Esophageal Cancer
Type
Observational
Design
  • Observational Model: Cohort
  • Time Perspective: Retrospective

Participation Requirements

Age
Between 18 years and 95 years
Gender
Both males and females

Description

From our prospectively build database 923 consecutive pT3 patients operated between january 1990 and june 2013 were selected. CRM status in patients treated by surgery only (n = 747) or after neoadjuvant therapy (n = 176) was recorded prospectively after surgery. Kaplan-Meier survival curves were ge...

From our prospectively build database 923 consecutive pT3 patients operated between january 1990 and june 2013 were selected. CRM status in patients treated by surgery only (n = 747) or after neoadjuvant therapy (n = 176) was recorded prospectively after surgery. Kaplan-Meier survival curves were generated, and factors affecting survival were assessed by Cox regression multivariate analysis.

Inclusion Criterias

pathologic T3 tumours of esophagus or GEJ
pathologic T3 tumours of esophagus or GEJ

Exclusion Criterias

R2 resections
pT other than pT3
R2 resections
pT other than pT3

Locations

Leuven, 3000
Leuven, 3000

Tracking Information

NCT #
NCT01959906
Collaborators
Not Provided
Investigators
  • Study Director: Philippe Nafteux, MD University Hospital Leuven, dept. Thoracic Surgery Principal Investigator: Katrien Van de Steen, MSc Katholic University Leuven
  • Study Director: Philippe Nafteux, MD University Hospital Leuven, dept. Thoracic Surgery Katrien Van de Steen, MSc Katholic University Leuven